Recent animal model studies of transient and permanent MCAO demonstrate that genetic deficiency or inhibition of tPA activity by neuroserpin decrease BBB disruption, edema, neuronal death, as well as improve stroke outcome (Wang et al., 1998; Tsuji et al., 2005). Here, PLAT is linked to Stroke.